Amid the COVID-19 crisis, the global market for Human Embryonic Stem Cell (hESC) Research estimated at US$650.9 Million in the year 2020, is projected to reach a revised size of US$1 Billion by 2027, growing at a CAGR of 6.5% over the analysis period 2020-2027. Regenerative Medicine, one of the segments analyzed in the report, is projected to record a 6.6% CAGR and reach US$717.5 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Stem Cell Biology Research segment is readjusted to a revised 7.4% CAGR for the next 7-year period.
The U.S. Market is Estimated at $192.2 Million, While China is Forecast to Grow at 6.1% CAGR
The Human Embryonic Stem Cell (hESC) Research market in the U.S. is estimated at US$192.2 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$177.3 Million by the year 2027 trailing a CAGR of 6.1% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 6.1% and 5.2% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 5.3% CAGR.
Tissue Engineering Segment to Record 5.1% CAGR
In the global Tissue Engineering segment, USA, Canada, Japan, China and Europe will drive the 5.1% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$39.3 Million in the year 2020 will reach a projected size of US$55.9 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$116.4 Million by the year 2027.We bring years of research experience to this 15th edition of our report. The 95-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.
Competitors identified in this market include, among others:
- Astellas Institute of Regenerative Medicine
- Asterias Biotherapeutics, Inc.
- BD Biosciences
- Cell Cure Neurosciences Ltd.
- Cellular Dynamics International
- GE Healthcare
- PerkinElmer, Inc.
- Reliance Life Sciences Ltd.
- Research & Diagnostics Systems, Inc.
- STEMCELL Technologies, Inc.
- Stemina Biomarker Discovery, Inc.
- Takara Bio, Inc.
- TATAA Biocenter AB
- Thermo Fischer Scientific Inc.
- UK Stem Cell Bank
- ViaCyte, Inc.
The global analysis and forecast periods covered within the report are 2020-2027 (Current & Future Analysis) and 2012-2019 (Historic Review). Research estimates are provided for 2020, while research projections cover the period 2021-2027.
I. INTRODUCTION, METHODOLOGY & REPORT SCOPE
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Stem Cells Research: A Sunrise Sector in Biotechnology Arena
Human Embryonic Stem Cells - An Introduction
Embryonic Stem Cells - Sources and Cell Culture
Comparison on Adult and Embryonic Stem Cells
Advantages and Drawbacks of Various Stem Cells
Recent Market Activity
Human Embryonic Stem Cells - The Market Perspective
Timeline for Embryonic Stem Cell Research Activities: Major Events from 1963 through 2014
Teratomas - No Longer an Impediment to Stem Cell Therapy Development
Human Embryonic and Induced Pluripotent Stem Cell Research Trends
Human Embryonic Stem Cell Research: Key Statistical Highlights
Research Topics on hESC and hiPSC by Number of Papers Published: 2011-2013
Haploid Human Embryonic Stem Cell Line: The New Frontier
Human Induced Pluripotent Stem Cells Remains Best Alternative for hESC
Global Competitor Market Shares
Human Embryonic Stem Cell (hESC) Research Competitor Market Share Scenario Worldwide (in %): 2018 & 2029
Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
Astellas Institute of Regenerative Medicine (US)
Asterias Biotherapeutics, Inc. (US)
BD Biosciences (US)
Cell Cure Neurosciences Ltd. (Israel)
Cellular Dynamics International (US)
GE Healthcare (UK)
MilliporeSigma (US)
PerkinElmer, Inc. (US)
Reliance Life Sciences Ltd. (India)
Research & Diagnostics Systems, Inc. (US)
SABiosciences Corp. (US)
STEMCELL Technologies, Inc. (Canada)
Stemina Biomarker Discovery, Inc. (US)
Takara Bio, Inc. (Japan)
TATAA Biocenter AB (Sweden)
Thermo Fisher Scientific, Inc. (US)
UK Stem Cell Bank (UK)
ViaCyte, Inc. (US)
Vitrolife AB (Sweden)
3. MARKET TRENDS & DRIVERS
Issues Hindering Development of hESC Research
Consideration of Best Translational Pathways Pivotal in Ensuring Growth Of hESCs
Ethical Issues and Technical Hurdles Bog Down hESC Research
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: Human Embryonic Stem Cell (hESC) Research Global Market Estimates and Forecasts in US$ Thousand by Region/Country: 2020-2027
TABLE 2: Human Embryonic Stem Cell (hESC) Research Market Share Shift across Key Geographies Worldwide: 2020 VS 2027
TABLE 3: Regenerative Medicine (Application) Global Opportunity Assessment in US$ Thousand by Region/Country: 2020-2027
TABLE 4: Regenerative Medicine (Application) Percentage Share Breakdown of Global Sales by Region/Country: 2020 VS 2027
TABLE 5: Stem Cell Biology Research (Application) Worldwide Sales in US$ Thousand by Region/Country: 2020-2027
TABLE 6: Stem Cell Biology Research (Application) Market Share Shift across Key Geographies: 2020 VS 2027
TABLE 7: Tissue Engineering (Application) Global Market Estimates & Forecasts in US$ Thousand by Region/Country: 2020-2027
TABLE 8: Tissue Engineering (Application) Market Share Breakdown by Region/Country: 2020 VS 2027
TABLE 9: Toxicology Testing (Application) Demand Potential Worldwide in US$ Thousand by Region/Country: 2020-2027
TABLE 10: Toxicology Testing (Application) Share Breakdown Review by Region/Country: 2020 VS 2027
III. MARKET ANALYSIS
GEOGRAPHIC MARKET ANALYSIS
UNITED STATES
Market Facts & Figures
US Human Embryonic Stem Cell (hESC) Research Market Share (in %) by Company: 2018 & 2025
Market Analytics
TABLE 11: United States Human Embryonic Stem Cell (hESC) Research Latent Demand Forecasts in US$ Thousand by Application: 2020 to 2027
TABLE 12: Human Embryonic Stem Cell (hESC) Research Market Share Breakdown in the United States by Application: 2020 VS 2027
CANADA
TABLE 13: Canadian Human Embryonic Stem Cell (hESC) Research Market Quantitative Demand Analysis in US$ Thousand by Application: 2020 to 2027
TABLE 14: Canadian Human Embryonic Stem Cell (hESC) Research Market Share Analysis by Application: 2020 VS 2027
JAPAN
TABLE 15: Japanese Demand Estimates and Forecasts for Human Embryonic Stem Cell (hESC) Research in US$ Thousand by Application: 2020 to 2027
TABLE 16: Human Embryonic Stem Cell (hESC) Research Market Share Shift in Japan by Application: 2020 VS 2027
CHINA
TABLE 17: Chinese Demand for Human Embryonic Stem Cell (hESC) Research in US$ Thousand by Application: 2020 to 2027
TABLE 18: Chinese Human Embryonic Stem Cell (hESC) Research Market Share Breakdown by Application: 2020 VS 2027
EUROPE
Market Facts & Figures
European Human Embryonic Stem Cell (hESC) Research Market: Competitor Market Share Scenario (in %) for 2018 & 2025
Market Analytics
TABLE 19: European Human Embryonic Stem Cell (hESC) Research Market Demand Scenario in US$ Thousand by Region/Country: 2018-2025
TABLE 20: European Human Embryonic Stem Cell (hESC) Research Market Share Shift by Region/Country: 2020 VS 2027
TABLE 21: European Human Embryonic Stem Cell (hESC) Research Addressable Market Opportunity in US$ Thousand by Application: 2020-2027
TABLE 22: European Human Embryonic Stem Cell (hESC) Research Market Share Analysis by Application: 2020 VS 2027
FRANCE
TABLE 23: Human Embryonic Stem Cell (hESC) Research Quantitative Demand Analysis in France in US$ Thousand by Application: 2020-2027
TABLE 24: French Human Embryonic Stem Cell (hESC) Research Market Share Analysis: A 7-Year Perspective by Application for 2020 and 2027
GERMANY
TABLE 25: Human Embryonic Stem Cell (hESC) Research Market in Germany: Annual Sales Estimates and Forecasts in US$ Thousand by Application for the Period 2020-2027
TABLE 26: Human Embryonic Stem Cell (hESC) Research Market Share Distribution in Germany by Application: 2020 VS 2027
ITALY
TABLE 27: Italian Demand for Human Embryonic Stem Cell (hESC) Research in US$ Thousand by Application: 2020 to 2027
TABLE 28: Italian Human Embryonic Stem Cell (hESC) Research Market Share Breakdown by Application: 2020 VS 2027
UNITED KINGDOM
TABLE 29: United Kingdom Demand Estimates and Forecasts for Human Embryonic Stem Cell (hESC) Research in US$ Thousand by Application: 2020 to 2027
TABLE 30: Human Embryonic Stem Cell (hESC) Research Market Share Shift in the United Kingdom by Application: 2020 VS 2027
REST OF EUROPE
TABLE 31: Rest of Europe Human Embryonic Stem Cell (hESC) Research Addressable Market Opportunity in US$ Thousand by Application: 2020-2027
TABLE 32: Rest of Europe Human Embryonic Stem Cell (hESC) Research Market Share Analysis by Application: 2020 VS 2027
ASIA-PACIFIC
TABLE 33: Human Embryonic Stem Cell (hESC) Research Quantitative Demand Analysis in Asia-Pacific in US$ Thousand by Application: 2020-2027
TABLE 34: Asia-Pacific Human Embryonic Stem Cell (hESC) Research Market Share Analysis: A 7-Year Perspective by Application for 2020 and 2027
REST OF WORLD
TABLE 35: Rest of World Human Embryonic Stem Cell (hESC) Research Market Quantitative Demand Analysis in US$ Thousand by Application: 2020 to 2027
TABLE 36: Rest of World Human Embryonic Stem Cell (hESC) Research Market Share Analysis by Application: 2020 VS 2027
IV. COMPETITION
Total Companies Profiled: 25
